Charlotte's Web Holdings, Inc.: insider trades · United States · SEC (Form 4)

About Charlotte's Web Holdings, Inc.

Charlotte’s Web Holdings, Inc. is a United States-based company focused on hemp extract and botanical wellness products. It is an SEC-reporting issuer with insider activity disclosed through Form 4 filings, and its shares are primarily followed in the U.S. small-cap / OTC ecosystem, while market references may also appear in the context of NYSE/NASDAQ screening and data feeds. For international investors, the company should be viewed as a consumer health and wellness name rather than a traditional pharmaceutical developer. Charlotte’s Web is headquartered in Louisville, Colorado, United States, and the business conducts the majority of its operations in the U.S. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1750155/000175015526000029/cweb-20251231.htm?utm_source=openai)) The company was built around its Charlotte’s Web brand and proprietary hemp genetics, evolving into a portfolio-led platform in cannabidiol (CBD) and related botanical ingredients. Its brand family currently includes Charlotte’s Web™, CBD Medic™, and CBD Clinic™, with positioning centered on wellness, self-care, and functional use cases. Core product categories include liquid hemp extract tinctures, gummies, capsules, topical creams and lotions, pet products, and, more recently, functional mushroom gummies. This broad but still focused range allows the company to address multiple consumer needs such as sleep, calm, daily wellness, recovery, and topical relief. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1750155/000175015526000029/cweb-20251231.htm?utm_source=openai)) Operationally, Charlotte’s Web relies on an integrated model spanning North American farm-grown hemp inputs, extraction, manufacturing, quality control, R&D, and distribution. A key asset is its cGMP-compliant production facility in Louisville, where the company manufactures tinctures and manages distribution and quality systems. Its products are sold through selected distributors, healthcare practitioners, the company’s own website, and third-party e-commerce channels. This vertical integration is important in a category where product consistency, trust, and compliance can be decisive competitive factors. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1750155/000175015526000029/cweb-20251231.htm?utm_source=openai)) From a competitive standpoint, Charlotte’s Web describes itself as a market leader in hemp extract wellness products in the United States. Its competitive strengths are brand recognition, proprietary hemp genetics, a diversified SKU set, and a long operating history in a still-developing consumer health niche. At the same time, the business remains exposed to pricing pressure, consumer demand swings, and regulatory uncertainty around hemp-derived products. For equity investors, the investment case is therefore a balance between brand equity and execution risk. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1750155/000175015526000029/cweb-20251231.htm?utm_source=openai)) A major recent development came on March 30–31, 2026, when the company announced a transaction with BAT involving the conversion of a C$75.3 million convertible debenture into common shares and a concurrent $10 million equity investment. That transaction is strategically important because it may materially reshape the company’s ownership structure and capital base. The company also reported its 2025 annual results in late March 2026, continuing to emphasize its leadership in CBD hemp extract wellness products. For French, Belgian, and Swiss investors, Charlotte’s Web is best characterized as a speculative U.S. consumer health small cap with meaningful dilution, funding, and execution considerations, but with a recognized brand and a clear niche in the U.S. wellness market. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001750155/000175015526000029/cweb-20251231.htm?utm_source=openai))